Tag archive for ‘Pharmaceutical sciences’
Jewish Business News On Thursday, October 1st, 2015

Teva Acquires Mexican Rimsa Pharmaceutical for $2.3 Billion

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is acquiring Rimsa,  an independent pharmaceutical company in Mexico with a portfolio of More...

Niva Goldberg On Sunday, July 26th, 2015

Three Way Takeover Battle: Teva Set to Buy Allergan’s Generics Unit – WSJ

Facebook0 Twitter Google Plus0 Pinterest0 Email Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s More...

Gil Tanenbaum On Monday, July 13th, 2015

JPay Makes Tablet for Inmates

Facebook0 Twitter Google Plus0 Pinterest0 Email – – Would you believe that there is now a tablet made especially for prisoners? Well there is! Florida’s JPay has introduced the new Android More...

Shiri Habib-Valdhorn On Wednesday, July 1st, 2015

Teva CEO: The Industry Is Undergoing a Shakeup

Facebook0 Twitter Google Plus0 Pinterest0 Email “Size is important in the industry, but it isn’t everything. It’s important to be better. You have to make acquisitions that will suit the More...

Jewish Business News On Friday, June 12th, 2015

The Durst Family Is Getting Into the Marijuana Business

Facebook0 Twitter Google Plus0 Pinterest0 Email – Alleged serial killer Robert Durst’s family is getting into the legal marijuana business. While Rob sits in prison awaiting trial on murder charges, More...

Ilan Shavit On Tuesday, June 2nd, 2015

Mylan to Teva: Stop Playing Games With Our Company

Facebook0 Twitter Google Plus0 Pinterest0 Email Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, More...

Shiri Habib-Valdhorn On Thursday, May 14th, 2015

Three Way Takeover Battle- Teva: We Can Close Mylan Deal in 2015

Facebook0 Twitter Google Plus0 Pinterest0 Email Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) CFO Eyal Desheh remains upbeat about Teva’s attempts to buy Mylan N.V. (Nasdaq: MYL). At the More...

Kurt Tucholsky On Wednesday, May 13th, 2015

Actavis CEO: Teva-Mylan Deal to Create ‘Bad Blood’, Destroy Value

Facebook0 Twitter Google Plus0 Pinterest0 Email     As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of rival More...

OPKO
Ilan Shavit On Wednesday, May 6th, 2015

Phillip Frost’s OPKO Health Acquires EirGen Pharma for $135 Million in Cash and Shares

Facebook0 Twitter Google Plus0 Pinterest0 Email   Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost,  has acquired EirGen Pharma, Ltd., a pharmaceutical company based More...

ELDAD TAMIR CAPITAL, LINKEDIN
Koby Yeshayahou On Tuesday, April 28th, 2015

Tamir Capital Soars After Court Ruling Against Teva

Facebook0 Twitter Google Plus0 Pinterest0 Email Shares in Tamir Capital are soaring on lively volumes, following a Tel Aviv District Court ruling that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: More...

Email:

Delivered by FeedBurner